
Elevated follistatin levels predict poor cardiometabolic outcomes.


coremsg

Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.

High Follistatin Predicts Poor Cardiometabolic Outcomes

high-follistatin-predicts-poor-cardiometabolic-outcomes-study-findings


High Follistatin Predicts Poor Cardiometabolic Outcomes: Study Findings
